Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Spotlight On: Ultragenyx sets $2.7 million price for newly approved GSDIa gene therapy
12+ hour, 12+ min ago (15+ words) FirstWord Pharma...
HHS asks public for input on US vaccine guidelines after Trump order
2+ day, 9+ hour ago (14+ words) FirstWord Pharma...
GSK kicks of Phase III studies to bring TSLP blockade to COPD
2+ day, 11+ hour ago (14+ words) FirstWord Pharma...
Pain drug developer Ambros to go public via reverse merger with Werewolf
2+ day, 15+ hour ago (14+ words) FirstWord Pharma...
Spotlight On: Checkpoint rivals sidelined as Padcev-Keytruda dominates bladder cancer care
3+ day, 6+ hour ago (13+ words) FirstWord Pharma...
Friday Five??? Cancer vaccine aims hit target, MAHA mainstay tapped to run FDA, AstraZeneca's hits soften a miss???and more
3+ day, 4+ hour ago (22+ words) Friday Five – Cancer vaccine aims hit target, MAHA mainstay tapped to run FDA, AstraZeneca's hits soften a miss…and more FirstWord Pharma...
Roche unveils $750M expansion to Oregon manufacturing site
3+ day, 9+ hour ago (10+ words) FirstWord Pharma...
Lilly links up with one of its Gateway Labs companies for vaccine collab
3+ day, 11+ hour ago (15+ words) FirstWord Pharma...
Amylyx preps for GLP-1 receptor antagonist launch with $500M share sale
3+ day, 19+ hour ago (13+ words) FirstWord Pharma...